Search Results 1-10 of 17178 for GLP-1 medication

  1. Diabetes drugs and weight loss - Mayo Clinic

    GLP-1 agonists mimic the way a hormone called glucagon-like peptide 1 works in the body. When blood sugar starts to rise after a person eats, these medicines ...

  2. Prescription weight-loss drugs - Mayo Clinic

    FDA's concerns with unapproved GLP-1 drugs used for weight loss. U.S. Food and Drug Administration. https://www.fda.gov/drugs/postmarket-drug-safety ...

  3. Semaglutide (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. ... This medicine comes with a Medication Guide and patient instructions. ... Do not keep ...

  4. Genetic test predicts response to weight-loss drugs - Mayo Clinic News Network

    ... medications: a first-generation weight loss drug, phentermine-topiramate (brand name Qsymia), and a newer GLP-1 drug, liraglutide (Saxenda). They found that ...

  5. Tirzepatide (subcutaneous route) - Side effects & dosage - Mayo Clinic

    ... glucagon-like peptide-1 (GLP-1) receptor agonist. ... This medicine comes with a Medication Guide and patient instructions. ... Do not keep outdated medicine or ...

  6. Effects Of Long-Acting GLP-1 (Glucagon-like Peptide-1) Or Dual Incretin (GLP-1 And GIP [Glucose-dependent Insulinotropic Peptide]) Modulation On Gastric Motor Functions - Mayo Clinic

    * Not currently on treatment (exceptions below) for cardiac, pulmonary, GI, hepatic, renal, hematological, neurological, or endocrine disorders. * Biological ...

  7. Diabetes treatment: Medications for type 2 diabetes - Mayo Clinic

    Tirzepatide (Mounjaro), a similar kind of medicine called a dual-acting GLP-1/GIP agonist. Action. Cause the release of insulin as blood sugar levels are ...

  8. Semaglutide (oral route) - Side effects & dosage - Mayo Clinic

    Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. ... This medicine should come with a Medication Guide. ... Do not keep outdated medicine or ...

  9. Liraglutide (subcutaneous route) - Side effects & dosage - Mayo Clinic

    This medicine is a glucagon-like peptide-1 (GLP-1) receptor agonist. Liraglutide injection is also used together with a reduced-calorie diet and proper ...

  10. New study links combination of hormone therapy and tirzepatide to greater weight loss after menopause - Mayo Clinic News Network

    ... GLP-1-based obesity medication semaglutide. No previous studies have examined whether hormone therapy might influence outcomes with tirzepatide. Dr ...